Scheld W Michael, Koedel Uwe, Nathan Barnett, Pfister Hans-Walter
Division of Infectious Diseases, Department of Internal Medicine, University of Virginia School of Medicine, PO Box 801342, Charlottesville, VA 22908, USA.
J Infect Dis. 2002 Dec 1;186 Suppl 2:S225-33. doi: 10.1086/344939.
No bacterial disease has undergone a more dramatic change in epidemiology during the past decade than acute bacterial meningitis. This review describes the changing epidemiology and considers some important recent observations that contribute to our understanding of the pathogenesis and pathophysiology of meningitis. The major focus is on the mechanisms of neuronal injury and the pathophysiologic concepts responsible for death and neurologic sequelae. In recent years, experimental studies have amplified our understanding of the substantial body of evidence that now implicates cytokines and chemokines, proteolytic enzymes, and oxidants in the inflammatory cascade leading to tissue destruction in bacterial meningitis. The molecular mechanisms responsible for oxidant-induced neuronal injury in meningitis are explored in some depth. Genetic targeting and/or pharmacologic blockade of the implicated pathways may be a future strategy for therapeutic adjunctive measures to improve outcome and may hold substantial promise, in concert with antimicrobial agents, in humans with acute bacterial meningitis.
在过去十年中,没有哪种细菌性疾病在流行病学方面的变化比急性细菌性脑膜炎更为显著。本综述描述了不断变化的流行病学情况,并探讨了一些近期的重要观察结果,这些观察结果有助于我们理解脑膜炎的发病机制和病理生理学。主要重点是神经元损伤的机制以及导致死亡和神经后遗症的病理生理概念。近年来,实验研究加深了我们对大量证据的理解,这些证据表明细胞因子、趋化因子、蛋白水解酶和氧化剂参与了细菌性脑膜炎中导致组织破坏的炎症级联反应。本文对脑膜炎中氧化剂诱导神经元损伤的分子机制进行了较为深入的探讨。对相关途径进行基因靶向和/或药物阻断可能是未来改善治疗结果的辅助治疗策略,并且与抗菌药物协同作用,对患有急性细菌性脑膜炎的人类可能具有巨大的前景。